Rankings
▼
Calendar
IMCR (Immunocore Holdings plc) Stock Financials & Earnings | Market Cap Arena
IMCR
Immunocore Holdings plc
Mkt Cap
$2B
Healthcare
·
Biotechnology
·
🇬🇧 United Kingdom
·
NASDAQ
Revenue (TTM)
$373M
Net Income (TTM)
-$27M
EPS (TTM)
-$0.54
Free Cash Flow (TTM)
-$15M
Gross Margin
98.7%
Op. Margin
-10.8%
Net Margin
-7.2%
FCF Margin
-4.0%
P/S Ratio (TTM)
4.6x
P/E Ratio (TTM)
—
YoY Rev Growth
+20.2%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$55M
$54M
-$15M
Q2 23
$60M
$59M
-$14M
Q3 23
$65M
$65M
-$14M
Q4 23
$71M
$71M
-$17M
Q1 24
$71M
$70M
-$26M
Q2 24
$75M
$74M
-$16M
Q3 24
$80M
$80M
-$9M
Q4 24
$84M
$84M
-$19M
Q1 25
$94M
$93M
-$4M
Q2 25
$98M
$97M
-$15M
Q3 25
$104M
$103M
-$7M
Q4 25
$77M
$75M
-$15M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
—
—
Q2 23
—
—
Q3 23
—
—
Q4 23
6.8x
—
Q1 24
6.4x
—
Q2 24
6.0x
—
Q3 24
5.7x
—
Q4 24
5.5x
—
Q1 25
5.1x
—
Q2 25
4.8x
—
Q3 25
4.5x
—
Q4 25
4.6x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$11M
$8M
Q2 23
$16K
-$1M
Q3 23
$9M
$9M
Q4 23
-$17M
-$18M
Q1 24
-$5M
-$5M
Q2 24
$23M
$23M
Q3 24
$21M
$20M
Q4 24
-$14M
-$18M
Q1 25
$435K
$137K
Q2 25
$26M
$26M
Q3 25
-$4M
-$5M
Q4 25
-$33M
-$36M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$3M
Q2 23
$1M
Q3 23
$730K
Q4 23
$711K
Q1 24
$430K
Q2 24
$331K
Q3 24
$828K
Q4 24
$4M
Q1 25
$298K
Q2 25
$414K
Q3 25
$748K
Q4 25
$3M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 24
+29.0%
+39.8%
Q2 24
+26.2%
+24.4%
Q3 24
+23.7%
+12.4%
Q4 24
+18.8%
+17.7%
Q1 25
+33.2%
+0.5%
Q2 25
+29.9%
+23.4%
Q3 25
+29.2%
+24.9%
Q4 25
-7.9%
-11.1%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$8M
15.1%
Q2 23
$0
0.0%
Q3 23
$0
0.0%
Q4 23
$0
0.0%
Q1 24
$9M
12.7%
Q2 24
$0
0.0%
Q3 24
$7M
8.2%
Q4 24
$9M
10.3%
Q1 25
$9M
10.1%
Q2 25
$10M
10.2%
Q3 25
$10M
9.5%
Q4 25
$8M
10.8%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q1 23
$37M
—
—
$33M
Q2 23
$38M
$21M
$14M
—
Q3 23
$43M
$23M
$12M
—
Q4 23
$46M
—
—
$42M
Q1 24
$57M
—
—
$39M
Q2 24
$51M
$26M
$13M
—
Q3 24
$53M
$24M
$12M
—
Q4 24
$61M
—
—
$42M
Q1 25
$56M
—
—
$40M
Q2 25
$69M
—
—
$43M
Q3 25
$71M
—
—
$40M
Q4 25
$58M
—
—
$31M
marketcaparena.com
Revenue Segments
Sale of Therapies
Quarter
Sale of Therapies
Q4 24
$84M
Q1 25
$94M
Q2 25
$98M
Q3 25
$104M
marketcaparena.com
Revenue by Geography
Europe
Rest of World
United States
International
Quarter
Europe
Rest of World
United States
International
Q1 24
$19M
$1M
$50M
—
Q2 24
$15M
$4M
$56M
—
Q3 24
$21M
$2M
$57M
—
Q1 25
$33M
—
$57M
$4M
Q2 25
$33M
$835K
$64M
—
Q3 25
$34M
$3M
$67M
—
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$417M
$0
$417M
Q2 23
$435M
$0
$435M
Q3 23
$443M
$0
$443M
Q4 23
$443M
$0
$443M
Q1 24
$833M
$0
$833M
Q2 24
$505M
$355M
$860M
Q3 24
$538M
$364M
$901M
Q4 24
$456M
$365M
$820M
Q1 25
$477M
$360M
$837M
Q2 25
$488M
$395M
$883M
Q3 25
$498M
$394M
$892M
Q4 25
$468M
$396M
$864M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
48M
—
Q2 23
49M
+1.1%
Q3 23
54M
+11.2%
Q4 23
49M
-9.7%
Q1 24
50M
+2.0%
Q2 24
50M
+0.3%
Q3 24
53M
+5.6%
Q4 24
50M
-5.3%
Q1 25
52M
+3.9%
Q2 25
50M
-3.2%
Q3 25
50M
+0.2%
Q4 25
50M
-0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 23
$502K
497
FY 24
$503K
493
FY 25
$568K
524
marketcaparena.com